Independent education resourceInformation here does not replace care from a qualified health professional.
Peptide Therapy GuideClear peptide education

Educational guide

New method reveals hidden protein motions for improved drug design

For many of us "protein" is the key element of a food order. However, beyond your preferred choice of meats or plant-based alternatives, proteins encompass a large class of complex biomolecules whose chemical structure is encoded in our genes. Proteins have cr

Written by Peptide Therapy Guide Editorial Team
For education only

This guide cannot diagnose a condition or recommend a personal treatment plan. Discuss medical questions with a qualified professional.

For many of us "protein" is the key element of a food order. However, beyond your preferred choice of meats or plant-based alternatives, proteins encompass a large class of complex biomolecules whose chemical structure is encoded in our genes. Proteins have critical functions in living cells, they help repair and build body tissues, drive metabolic reactions, maintain pH and fluid balance, and keep our immune systems strong.

To perform their important functions many proteins have a dynamic molecular structure capable to adopt multiple conformations. For a long time, scientists have suspected that proteins don't change shape at random. Instead, they seem to move according to deep, slow rhythms-like a building that sways gently in the wind rather than shaking violently. Those slow rhythms guide how a protein bends, twists, and shifts between its different forms. If one could understand those rhythms, one might be able to predict-and even hurry along-the protein's movements.

The problem is that many tools scientists have to make predictions of molecular motion were built for simpler cases. They work well for fast, tiny vibrations, like the quick trembling of a guitar string. But the slow, sweeping motions of proteins are different. They're messy, uneven, and irregular.

Recently, the research group of associate professor Matthias Heyden in ASU's School of Molecular Sciences has found a new way forward. They developed a method that can tease out these slow, important motions from short computer simulations-snapshots lasting only billionths of a second. Even better, the method is remarkably reliable: run it again and again, and it tells the same story each time. They have recently published this work in Science Advances.

Better understanding protein fluctuations, in turn predicts which larger motions the protein is capable of, and that knowledge can greatly improve drug design, enable more effective cancer treatments and help find a solution to antibiotic resistance.

"In short, we resurrected a longstanding idea that conformational transitions in proteins are tied to low-frequency vibrations," describes Heyden as the approach of his team.

"We developed a method to identify these vibrations through natural fluctuations caused by molecular collisions. The natural motions stand out if analyzed with the right tools.

This can be compared to an unlocked door: we can feel quickly if we need to push or pull, while trying to yank the door up and off of its hinges is always hard. The key is that we don't need to execute the full motion to realize these differences. On a molecular scale, it is even enough to observe tiny fluctuations that are always present at room temperature."

Heyden continues to explain that: "Knowing the low-frequency vibrations of a protein should enable us to speed up the sampling of conformational transitions in molecular dynamics simulations."

Once they had uncovered these hidden rhythms, they used them like guide rails. In simulations of five very different proteins. They gently nudged each protein to move along its natural pathways, encouraging it to explore all the shapes it prefers to adopt. This approach allowed them to map the protein's landscape-where it likes to linger, where it resists change, and how much energy it takes to move from one form to another-with impressive accuracy.

Heyden goes on to explain that in the context of recent developments such as AlphaFold, which can predict the structures of proteins based on their sequence alone, fast simulation methods like the one his team has developed, will enable the generation of datasets that expand the "sequence-to-structure" relationship captured by AlphaFold to "sequence-to-structure-to-dynamics" relationships.

What makes this especially exciting is speed. By harnessing powerful graphics processors on ASU's "Sol" supercomputer, they can now watch proteins undergo meaningful shape changes in less than a day. What once required weeks or even months of computation can now happen overnight.

That matters because most designed proteins today are rigid and dull compared to nature's creations. They hold their shape well, but they don't do much. By understanding motion and change, scientists could design proteins that switch on when a small molecule binds, act as sensitive detectors, or perform chemical reactions like natural enzymes.

There's another payoff, too. Many important drug targets work through subtle, long-distance communication within the protein-touch it in one place, and something changes far away. These "allosteric" effects are notoriously hard to study. With faster, more revealing simulations, researchers can finally watch these internal conversations unfold, paving the way for drugs that fine-tune protein behavior with fewer side effects.

In short, by learning to listen to the slow music proteins move to, scientists are beginning to understand not just what proteins are, but how they live. What once took deep intuition and careful manual selection of variables could now be done systematically and efficiently.

This high-throughput generation of conformational ensembles has opened a new door. With richer and more diverse datasets, researchers could train next-generation machine learning models capable of understanding the intertwined relationships between protein sequence, structure, and dynamics.

This work was supported by the National Science Foundation (CHE-2154834) and the National Institutes of Health (R01GM148622).

Sauer, M. A., et al. (2026). Fast sampling of protein conformational dynamics. Science Advances. DOI: 10.1126/sciadv.aea4617. https://www.science.org/doi/10.1126/sciadv.aea4617

Connected reading

Helpful context for this guide

Source-derived material selected through this article’s indexed topics.

Related questions

01You have worked across the full drug development pipeline. How has that experience shaped your view of where AI can have the greatest impact in drug safety discovery?

Having worked across different parts of the discovery process, I think broad exposure changes the way you think. I have developed quantum chemistry, artificial intelligence (AI) and machine learning (ML) methods in research settings, but I have also had the chance to apply them in real discovery environments for materials and pharmaceuticals. That experience has shown me how different parts of the discovery pipeline interact, what their motivations are, and how they communicate. AI and ML have been used in early discovery for many years, but the biggest recent shift is in areas dominated by human processes and communication. Computers can now interact directly with human language and analytical images, opening new applications such as AI research assistants and AI-assisted dossier drafting. That means AI can start to work more collaboratively with scientists, although expert oversight and guardrails remain essential. In nonclinical safety, I think the biggest impact will be AI working alongside safety scientists to unearth key data, connect safety science with earlier discovery and later clinical work, and help process, predict, and summarize important outcomes. That could help safety science integrate more tightly with design, make, and test cycles in discovery, while also interfacing earlier with clinical science. Save a Copy of This Exclusive Interview by Downloading the Free PDF

Source: www.news-medical.net ↗
02How important is it to pick the right target in drug discovery? Could artificial intelligence (AI) be used to aid this process?

Picking the right target is absolutely fundamental. I mentioned that over half of failures of new medicines in development are due to us picking the wrong target. Even if we just doubled our success rate at picking the right target, it would have a huge impact on the development of new medicines for people. One of the reasons, and why I think artificial intelligence could be really important in helping us do that, is that, quite often, there may be some data buried in the literature that tells us a target is really good. Equally valuable is the fact that there may be something buried in the literature that tells you a target is not good. It's much harder to publish negative data than positive data. That target invalidation can be just as valuable as a target validation. It's really about being able to tap into all that knowledge and look up all the facts. That would mean that our systems and other people's AI systems can really be much more effective at picking the right target.

Source: www.news-medical.net ↗
03How will this discovery change cancer science?

This is a win for the field. Until now, we have been focused on immune therapies that might make tumors more vulnerable to the body's immune system, and on finding new chemotherapy combinations that kill cancer cells. This new treatment has given us a new focus, and I think it will spur a lot of scientific discovery over the next few years. There have only been a handful of KRAS researchers and their relevance to therapy was always questioned. That is about to change. The most important next step for the field is to better understand the biology of cancer. We know that many pancreatic tumors will eventually become resistant to daraxonrasib, and we need to understand how this happens. We also need to identify additional genetic pathways and treatments that can target them. That's how we will turn pancreas cancer from a deadly, deadly cancer into something we can manage-and one day, even cure.

Source: www.news-medical.net ↗
04How long does it take for vitamins to work?

Biologically, vitamins are absorbed within hours and have instant metabolic effects, such as antioxidants that protect cells or compounds that are building blocks for making hormones. But, many factors impact their efficiency and could keep your body from fully absorbing them. Absorption and effects depend on each individual and what combination of vitamins they take. Gender, age, digestive health, medical conditions, and diet all play a role. One helpful practice to detect deficiencies is to look for the symptoms deficiencies create. Then, look for improvement in your symptoms with supplement intake. You are unlikely to see or feel changes if you do not lack nutrients. If you are chronically tired or see signs of unhealthy nails, hair, or skin, supplements may help as these are indicators that you are lacking nutrients in your diet. If you are unsure, your doctor can order tests to check for deficiencies in your blood.

Source: www.medicinenet.com ↗
05What are carbs?

Your weight loss plan should keep you healthy and strong as you lose the extra weight. Many plans include a diet low in carbohydrates. Carb cycling is a method of optimizing your carbohydrate intake to meet your needs while dieting, fasting, and working out. When you're carb cycling, you consume carbs to meet your needs on some days and avoid them on other days. The aim of carb cycling is to consume carbohydrates when your body needs them and exclude them at other times. Such strategies in your diet plan can help your weight loss efforts. Carbohydrates, or carbs, are a significant part of the average human diet. Along with proteins and fats, they make up the bulk of your daily meals. Most carbohydrates are broken down by your body into glucose to provide energy for your cells and tissues. Carbohydrates in your diet are of three types — sugars, starches, and fiber. Sugars are simple carbs. Glucose, sugar (sucrose), lactose found in milk, and fructose found in fruits, are naturally occurring sugars. Your body metabolizes these molecules rapidly to yield energy. Starches are complex carbs. They're large molecules that consist of hundreds of molecules of simple sugars joined together. Your body needs to break them down to release energy. Starches are found in bread, potatoes, peas, corn, cereals, and pasta. Fiber is also a complex carbohydrate. Human bodies can't break down these large molecules, so they provide no energy. They're usually excreted as they are in the feces. They add bulk to your meal, so you feel full. Fiber in the diet helps avoid constipation and lowers blood sugar and cholesterol levels. Carbohydrates are an essential part of your diet. A typical diet provides 45% to 65% of its calories from carbohydrates. If you have 2,000 calories a day, you should have about 275 grams of carbohydrates. Always try to choose healthy foods for your carb intake:

Source: www.medicinenet.com ↗
P

About the author

Peptide Therapy Guide Editorial Team

Editorial team for Peptide Therapy Guide.

View all articles →